IFNL3 and hepatitis C virus infection: Indeed, GWAS have yielded important pharmacogenetic findings (for example, identifying IFNL3/IL28B gene polymorphisms associated with interferon/ribavirin response in hepatitis C therapy) that later became features in machine learning models [13].